- Home
- TIPT vs CMPX Comparison
TIPT vs CMPX Comparison
Compare TIPT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIPT
- CMPX
- Stock Information
- Founded
- TIPT 2007
- CMPX 2014
- Country
- TIPT United States
- CMPX United States
- Employees
- TIPT N/A
- CMPX N/A
- Industry
- TIPT Property-Casualty Insurers
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- TIPT Finance
- CMPX Health Care
- Exchange
- TIPT Nasdaq
- CMPX Nasdaq
- Market Cap
- TIPT 719.0M
- CMPX 752.4M
- IPO Year
- TIPT 2007
- CMPX N/A
- Fundamental
- Price
- TIPT $18.64
- CMPX $4.91
- Analyst Decision
- TIPT
- CMPX Strong Buy
- Analyst Count
- TIPT 0
- CMPX 7
- Target Price
- TIPT N/A
- CMPX $14.43
- AVG Volume (30 Days)
- TIPT 220.9K
- CMPX 1.9M
- Earning Date
- TIPT 10-31-2025
- CMPX 11-05-2025
- Dividend Yield
- TIPT 1.32%
- CMPX N/A
- EPS Growth
- TIPT 17.79
- CMPX N/A
- EPS
- TIPT 1.15
- CMPX N/A
- Revenue
- TIPT $2,070,076,000.00
- CMPX N/A
- Revenue This Year
- TIPT N/A
- CMPX N/A
- Revenue Next Year
- TIPT N/A
- CMPX N/A
- P/E Ratio
- TIPT $16.23
- CMPX N/A
- Revenue Growth
- TIPT 4.25
- CMPX N/A
- 52 Week Low
- TIPT $17.07
- CMPX $1.33
- 52 Week High
- TIPT $27.41
- CMPX $5.11
- Technical
- Relative Strength Index (RSI)
- TIPT 50.54
- CMPX 67.40
- Support Level
- TIPT $18.11
- CMPX $4.79
- Resistance Level
- TIPT $19.33
- CMPX $5.11
- Average True Range (ATR)
- TIPT 0.50
- CMPX 0.32
- MACD
- TIPT 0.07
- CMPX 0.05
- Stochastic Oscillator
- TIPT 56.49
- CMPX 86.34
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.